OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
These highlights do not include all the information needed to use OXYCONTIN ® safely and effectively. See full prescribing information for OXYCONTIN. OXYCONTIN ® (oxycodone hydrochloride) extended-release tablets, for oral use, CII Initial U.S. Approval: 1950
These highlights do not include all the information needed to use OXYCODONE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for OXYCODONE HCl EXTENDED-RELEASE TABLETS. OXYCODONE HCl EXTENDED-RELEASE TABLETS, for oral use, CII Initial U.S. Approval: 1950
These highlights do not include all the information needed to use OXYCODONE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for OXYCODONE HCl EXTENDED-RELEASE TABLETS. OXYCODONE HCl EXTENDED-RELEASE TABLETS, for oral use, CII Initial U.S. Approval: 1950
Amneal Pharmaceuticals of New York LLC | Anderson Packaging, Inc | Purdue Pharmaceuticals L.P. | Sharp Packaging Solutions